Executive Summary:
The Ministry of Chemicals and Fertilizers addresses the Strengthening of Pharmaceuticals Industry Scheme (SPI) in response to Lok Sabha Unstarred Question No. 2252, answered on August 1, 2025. The scheme provides financial assistance through two sub-schemes: APICF for infrastructure in pharmaceutical clusters and RPTUAS for technology upgrades. As of July 29, 2025, significant funds have been allocated, applications processed, and outreach events conducted.
Key Points / Main Content:
Strengthening of Pharmaceuticals Industry Scheme (SPI):
Two sub-schemes provide financial assistance:
Assistance to Pharmaceutical Industry for Common Facilities (APICF): Supports infrastructure in pharmaceutical clusters.
Revamped Pharmaceutical Technology Upgradation Assistance Scheme (RPTUAS): Aids technology upgrades to meet Schedule M or WHOGMP standards.
Financial Assistance Under RPTUAS:
₹300.10 crore allocated for FY2024-25 to FY2025-26.
281 applications received as of July 29, 2025.
142 applications approved with a total grant-in-aid of ₹135.8 crore.
₹5.96 crore approved for five companies in Andhra Pradesh.
Funds disbursement contingent on certification of compliance with revised Schedule M and WHOGMP norms. No funds disbursed yet as projects are in implementation phase. Annexure I and II lists the pharmaceutical companies.
Financial Assistance Under APICF:
₹178.40 crore allocated for FY2024-25 to FY2025-26.
Projects approved involve a total grant-in-aid of ₹139.33 crore to special purpose vehicles (SPVs).
₹20 crore approved for a project in Andhra Pradesh.
₹75.76 crore disbursed so far, including ₹5 crore for the Andhra Pradesh project. Annexure III lists the SPVs considered and approved.
Awareness and Outreach:
13 national conferences and 5 webinars conducted in association with industry associations.
Events focused on enhancing pharmaceutical quality assurance through Good Manufacturing Practices and RPTUAS.
Conferences held across various states, and webinars held in Chennai, Bangalore, Hyderabad, Ahmedabad and Vadodara.
Monitoring Mechanisms:
Applicants under RPTUAS must submit revised Schedule M/WHOGMP certificates from drug regulators and expenditure certificates from chartered accountants to claim incentive.
Verification of Schedule M/WHOGMP certificates is undertaken with Joint Drugs Controller General India and State Drugs Controllers via videoconferencing.
Impact Analysis:
Pharmaceutical Units:
Impact: Access to financial assistance for technology upgrades and infrastructure development.
Action Required: Submit applications under RPTUAS and APICF, comply with Schedule M and WHOGMP standards, and provide necessary certifications for fund disbursement.
Drug Regulatory Authorities:
Impact: Responsible for certifying compliance with Schedule M and WHOGMP norms.
Action Required: Verify submitted certificates and participate in monitoring meetings to expedite verification processes.
Industry Associations:
Impact: Collaboration with the government in organizing awareness and outreach campaigns.
Action Required: Continue to partner with the government to promote the benefits of the scheme and ensure broad participation from pharmaceutical clusters.
Key Entities Referenced
Strengthening of Pharmaceuticals Industry Scheme SPI: A scheme by the Government of India to strengthen the pharmaceutical industry.
Andhra Pradesh: A state in India, specifically mentioned in the context of registered pharmaceutical units and financial outlay.
Assistance to Pharmaceutical Industry for Common Facilities APICF: A sub-scheme under SPI that provides financial assistance for infrastructure facilities in pharmaceutical clusters.
Revamped Pharmaceutical Technology Upgradation Assistance Scheme RPTUAS: A sub-scheme under SPI that provides financial assistance for upgrading technology in pharmaceutical units.
Revised Schedule M: A set of standards under the Drugs Rules, 1945, for pharmaceutical manufacturing practices.
World Health Organization Good Manufacturing Practices WHOGMP: Internationally recognized standards for good manufacturing practices in the pharmaceutical industry.
Drugs Rules, 1945: A set of rules governing the regulation of drugs in India.
Telangana Hyderabad: A city and state in India, specifically mentioned in the context of location of conferences, webinars, SPVs
GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
DEPARTMENT OF PHARMACEUTICALS
LOK SABHA
UNSTARRED QUESTION No. 2252
TO BE ANSWERED ON THE 01st AUGUST 2025
Strengthening of the Pharmaceutical Industries
2252. Shri Daggumalla Prasada Rao:
Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:
(a) the details of pharmaceutical units registered and shortlisted under the Strengthening of
Pharmaceuticals Industry Scheme (SPI), year-wise, State/district-wise for Andhra Pradesh;
(b) the details of financial outlay sanctioned and utilised by the pharmaceutical units under
the said scheme classified by their annual turnover for Andhra Pradesh, State-wise and
district-wise;
(c) whether the Government has undertaken any awareness and outreach campaigns for the
revamped scheme in pharmaceutical clusters, if so, the number and type of such events
held, State-wise; and
(d) the monitoring mechanisms put in place to verify certified expenditures, compliance
with Revised Schedule M and WHO-GMP norms?
ANSWER
THE MINISTER OF STATE IN THE MINISTRY OF CHEMICALS AND
FERTILIZERS
(SMT. ANUPRIYA PATEL)
(a) and (b): Pharmaceutical units are being provided financial assistance under the
following two sub-schemes under the Strengthening of Pharmaceuticals Industry scheme:
(i) Assistance to Pharmaceutical Industry for Common Facilities (API-CF): Under
this, financial assistance is provided for infrastructure facilities in pharmaceuticals
clusters.
(ii) Revamped Pharmaceutical Technology Upgradation Assistance Scheme
(RPTUAS): Under this, financial assistance is provided for upgrading technology
in pharmaceuticals units to Schedule M or World Health Organization — Good
Manufacturing Practices (WHO-GMP) standards.
Under RPTUAS, issued in September 2024, a total amount of ₹300.10 crore has
been allocated for various pharmaceutical units for the period from the financial year (FY)
2024-25 to FY2025-26. As on 29.7.2025, 281 applications have been received from
pharmaceutical units under the sub-scheme and applications of 142 pharmaceutical
companies have been approved with total approved grant-in-aid amount of ₹135.8 crore
for their projects, which include applications of five pharmaceutical companies with total
approved grant-in-aid amount of ₹5.96 crore in the State of Andhra Pradesh. Release and
utilisation of financial assistance under the scheme is to be done on receipt of certificationby the drug regulatory authority concerned regarding compliance with the revised Schedule
M to the Drugs Rules, 1945 and the World Health Organization — Good Manufacturing
Practices. The approved projects are at various stages of implementation and have not
reached the stage of certification as aforesaid and, therefore, funds have so far not been
disbursed under the sub-scheme. List of pharmaceutical companies whose projects have
been considered and approved under the scheme is at Annexure I. List of pharmaceutical
companies whose projects are under consideration under the sub-scheme are at Annexure
II.
Under API-CF, a total amount of ₹178.40 crore has been allocated for various
projects for the period from FY2024-25 to FY2025-26. Projects approved or approved in-
principle so far involve total grant-in-aid amount of ₹139.33 crore to special purpose
vehicles formed by pharmaceutical companies, including one project for a special purpose
vehicle formed involving total approved grant-in-aid of ₹20 crore in the State of Andhra
Pradesh. Total amount disbursed so far in respect of the approved projects is ₹75.76 crore,
including disbursed amount of ₹5 crore in respect of the project in the State of Andhra
Pradesh. List of pharmaceutical companies whose projects have been considered and
approved or approved in-principle under the scheme is at Annexure III.
(c): The Government, in association with industry associations, has so far organised 13
national conferences and five webinars with pharmaceutical clusters on Enhancing
Pharmaceuticals Quality Assurance through Good Manufacturing Practices and Session on
RPTUAS. These National conferences were held in Himachal Pradesh (Baddi), Gujarat
(Ahmedabad), Bihar (Aurangabad), Telangana (Hyderabad), Andhra Pradesh (Vizag),
Maharashtra (Pune), Goa (Panjim), West Bengal (Kolkata), Madhya Pradesh (Indore),
Odisha (Bhubaneswar), Maharashtra (Mumbai), Karnataka (Mysore) and Gujarat
(Vadodara). The webinars with pharmaceutical clusters have been held at Chennai,
Bangalore, Hyderabad, Ahmedabad and Vadodara.
(d): Under RPTUAS, to claim the incentive amount, applicants are required to submit the
revised Schedule M / WHO-GMP certificates issued by the drug regulators concerned and
certificate of expenditure incurred issued by charted accountant. Verification of the revised
Schedule M / WHO-GMP certificates submitted by applicants from the drug regulator
concerned is undertaken. Further, meetings through videoconferencing are held from time
to time, with participation of Joint Drugs Controller General (India) and State Drugs
Controllers concerned, to monitor and expedite such verification.Annexure I
Statement referred to in reply to part (a) of the LOK SABHA UNSTARRED Q. NO.
2252 for answer on 1.8.2025
List of pharmaceutical companies whose projects have been considered and
approved under RPTUAS
State / Union Sanctioned in
Applicant pharmaceutical company
territory financial year
Dinakara Life Science Pvt. Ltd. Andhra Pradesh 2024-25
Alapati Pharma Andhra Pradesh 2024-25
Inchem Laboratories Pvt. Ltd. Andhra Pradesh 2024-25
Aparna Pharmaceuticals Pvt. Ltd. Andhra Pradesh 2025-26
Alivira Animal Health Ltd. Andhra Pradesh 2025-26
Signova Healthcare Pvt. Ltd. Unit-II Assam 2025-26
Ornate Labs Pvt. Ltd. Bihar 2024-25
Anuja Healthcare Ltd. Chandigarh 2024-25
V S International Pvt. Ltd. Daman 2025-26
Bdr Lifesciences Pvt. Ltd. Gujarat 2024-25
Sangharsh Lifecare Pvt. Ltd. Gujarat 2024-25
Denis Chem Lab Ltd Gujarat 2024-25
Bakul Pharma Pvt. Ltd. Gujarat 2024-25
Navil Laboratories Pvt. Ltd. Gujarat 2024-25
Virdev Intermediates Pvt. Ltd. Gujarat 2024-25
Altis Finchem Pvt. Ltd. Gujarat 2024-25
Kentreck Laboratories Pvt. Ltd. Gujarat 2024-25
Neha Life Science Pvt. Ltd. Gujarat 2024-25
Vasa Pharmachem Pvt. Ltd. Gujarat 2024-25
Arnav Research Laboratories Gujarat 2024-25
Nucare Laboratories India Gujarat 2024-25
Adrhim Pharmaceuticals LLP Gujarat 2024-25
Swati Chemicals Gujarat 2024-25
B. Sharda Pharma Pellets Pvt. Ltd. Gujarat 2024-25
Exotic Pharma Gujarat 2024-25
Padmavati Chemicals Pvt. Ltd. Gujarat 2024-25
Shiva Healthcare Gujarat 2024-25
Shc Pharmaceuticals Gujarat 2024-25
Yash Medicare Pvt. Ltd. Gujarat 2024-25
Exemed Pharmaceuticals Gujarat 2025-26
Salus Pharmaceuticals Gujarat 2025-26
Trio Remedies Pvt. Ltd. Gujarat 2025-26
Trio Lifescience Pvt. Ltd. Gujarat 2025-26
Pulse Pharma Manu Co Gujarat 2025-26
Rajdip Pharmaceuticals Gujarat 2025-26
Sanket Healthcare Gujarat 2025-26
C P M Enterprise Gujarat 2025-26
Maruti Industries Gujarat 2025-26
Sahajanand Life Sciences Pvt. Ltd. Gujarat 2025-26Protech Biosystem Pvt. Ltd. Haryana 2025-26
Mcneil And Argus Pharmaceuticals Ltd. Haryana 2024-25
Ethix Health Care Himachal Pradesh 2024-25
Bennet Pharmaceuticals Ltd. Himachal Pradesh 2024-25
Maxwell Pharma Himachal Pradesh 2024-25
M Sea Pharmaceuticals Pvt. Ltd. Himachal Pradesh 2024-25
Park Pharmaceuticals Himachal Pradesh 2024-25
Three B Healthcare Ltd. Himachal Pradesh 2024-25
Auraya Healthcare Unit-II Himachal Pradesh 2024-25
Medoz Pharmaceuticals Pvt. Ltd. Himachal Pradesh 2024-25
Unispeed Pharmaceuticals Pvt. Ltd. Himachal Pradesh 2024-25
Pharma Force Lab Himachal Pradesh 2024-25
Sirmour Remedies Pvt. Ltd. Himachal Pradesh 2024-25
Mediforce Healthcare Pvt. Ltd. Himachal Pradesh 2024-25
Goish Remedies Ltd. Himachal Pradesh 2024-25
Alexi Pharmicia Pvt. Ltd. Himachal Pradesh 2024-25
Biodeal Pharmaceuticals Ltd. Himachal Pradesh 2024-25
Brit Lifescience Himachal Pradesh 2024-25
Higgs Healhtcare Himachal Pradesh 2024-25
Unix Biotech Himachal Pradesh 2024-25
Varv Biogenesis Pvt. Ltd. Himachal Pradesh 2024-25
Next Wave India Himachal Pradesh 2024-25
Gnosis Pharmaceuticals Pvt. Ltd. Himachal Pradesh 2024-25
Medicef Pharma Himachal Pradesh 2024-25
Algen Healthcare Ltd. Himachal Pradesh 2024-25
Brd Medilabs Himachal Pradesh 2024-25
Nixi Laboratories Pvt. Ltd. Himachal Pradesh 2024-25
Legen Healthcare Himachal Pradesh 2024-25
Osper Formulation Pvt. Ltd. Himachal Pradesh 2024-25
Caspian Pharmaceuticals Himachal Pradesh 2025-26
Purobien Lifesciences Himachal Pradesh 2025-26
Saphnix Life Sciences Himachal Pradesh 2025-26
Dm Pharma Pvt. Ltd. Himachal Pradesh 2025-26
Healkraft Pharma (India) Pvt. Ltd. Himachal Pradesh 2025-26
Vowcare Products Jammu and Kashmir 2024-25
Protech Biopharma Pvt. Ltd. Jammu and Kashmir 2024-25
Ce Chem Pharmaceuticals Pvt. Ltd. Karnataka 2024-25
Nandu Chemical Industries Karnataka 2024-25
Recipharm Pharmaservices Pvt. Ltd. Karnataka 2024-25
Nandu Chemicals Pvt. Ltd. Karnataka 2025-26
Anglo-French Drugs & Industries Ltd. Karnataka 2025-26
Kemwell Biopharma Pvt. Ltd. Karnataka 2025-26
Chethana Formulations Pvt. Ltd. Kerala 2025-26
Megasys Biotek Pvt. Ltd. Kerala 2025-26
Labinduss Ltd Kerala 2025-26
Zenith Drugs Ltd. Madhya Pradesh 2024-25
Schon Pharmaceuticals Ltd. Madhya Pradesh 2024-25
Modern Laboratories Madhya Pradesh 2024-25Nandani Medical Laboratories Pvt. Ltd. Madhya Pradesh 2025-26
Hind Pharma Madhya Pradesh 2025-26
Beryl Drugs Ltd. Madhya Pradesh 2025-26
Scitech Specialities Pvt. Ltd. Maharashtra 2024-25
Murli Krishna Pharma Pvt. Ltd. Maharashtra 2024-25
Aqua Fine Injecta Pvt. Ltd. Maharashtra 2024-25
Emil Pharmaceutical Industries Pvt. Ltd Maharashtra 2024-25
Srikem Laboratories Pvt. Ltd. Maharashtra 2024-25
Sunshine Organics Pvt. Ltd. Maharashtra 2024-25
Embio Ltd. Maharashtra 2024-25
Aveo Pharmaceuticals Pvt. Ltd. Maharashtra 2024-25
Hindustan Antibiotics Ltd. Maharashtra 2024-25
Sequent Scientific Ltd. Maharashtra 2024-25
Kores (India) Ltd. Maharashtra 2024-25
Nitika Pharmaceutical Specialities Pvt. Ltd. Maharashtra 2024-25
Avik Pharmaceutical Ltd. Maharashtra 2024-25
Great Pacific Export Pvt. Ltd. Maharashtra 2024-25
Vav Lipids Pvt. Ltd. Maharashtra 2025-26
Anek Prayog Pvt. Ltd. Maharashtra 2025-26
Velite Pharmaceuticals Punjab 2024-25
Systacare Remedies Punjab 2024-25
Saurav Chemicals Ltd. Punjab 2024-25
Torque Pharmaceuticals Pvt. Ltd. Punjab 2024-25
Lark Laboratories India Ltd Rajasthan 2024-25
Saimirra Innopharm Pvt. Ltd. Tamilnadu 2024-25
Pharm Products Pvt. Ltd. Tamilnadu 2024-25
Medibest Pharma Pvt. Ltd Tamilnadu 2024-25
Tychos Therapeutics Pvt. Ltd. Tamilnadu 2024-25
Sreepathi Pharmaceuticals Ltd. Telangana 2024-25
Dano Vaccines & Biologicals Pvt. Ltd. Telangana 2024-25
Magnum Chemi Gran Pvt. Ltd. Telangana 2024-25
Sanzyme Pvt. Ltd.. Telangana 2024-25
Radicon Laboratories Ltd. Uttar Pradesh 2024-25
Daffodills Pharmaceuticals Ltd. Uttar Pradesh 2024-25
Pro-Pharma Care Pvt Uttarakhand 2024-25
Daffohils Laboratories Pvt. Ltd. Uttarakhand 2024-25
Sarv Pharmaceuticals Uttarakhand 2024-25
Talent Healthcare Uttarakhand 2024-25
Prochem Pharmaceuticals Pvt. Ltd. Uttarakhand 2024-25
Tosc International Pvt. Ltd. Uttarakhand 2024-25
Karnani Pharmaceuticals Pvt. Ltd. Uttarakhand 2024-25
Evolet Pharmaceuticals Pvt. Ltd. Uttarakhand 2024-25
Rusan Pharma Ltd. Uttarakhand 2025-26
Cotec Health Care Pvt. Ltd. Uttarakhand 2025-26
Tulbros Formulations Uttarakhand 2025-26
Indian Drug Vision Uttarakhand 2025-26
Aagya Biotech Pvt. Ltd. Uttarakhand 2025-26
Vulcan Laboratories Pvt. Ltd. West Bengal 2024-25Mendine Pharmaceuticals Pvt. Ltd. West Bengal 2024-25
Diamond Drugs Pvt. Ltd. West Bengal 2024-25
Gena Pharmaceuticals Ltd. West Bengal 2024-25
Pharma Impex Laboratories Pvt. Ltd. West Bengal 2024-25
Tetradrip Pharma Pvt. Ltd. West Bengal 2025-26
Jagannath Chemical and Pharmaceutical 2025-26
West Bengal
Works Pvt. Ltd.
Hygeia Pharmaceuticals Mfg Pvt. Ltd. West Bengal 2025-26Annexure II
Statement referred to in reply to part (a) of the LOK SABHA UNSTARRED Q. NO.
2252 for answer on 1.8.2025
List of pharmaceutical companies whose projects are under consideration under
RPTUAS
Sanctioned
State / Union
Applicant pharmaceutical company in financial
territory
year
Rathnam Pharmaceuticals Andhra Pradesh 2025-26
Sionc Pharmaceutical Pvt. Ltd. Andhra Pradesh 2025-26
Padmaja Laboratories Pvt. Ltd. Andhra Pradesh 2025-26
Serve Pharmaceuticals Gujarat 2025-26
Narmada Organics Gujarat 2025-26
Bdr Pharmaceuticals International Pvt. Ltd. Gujarat 2025-26
Intracin Pharmaceuticals Pvt. Ltd. Gujarat 2025-26
Manish Pharma Lab Gujarat 2025-26
Parth Laboratories Pvt. Ltd. Gujarat 2025-26
Lactose India Ltd. Gujarat 2025-26
Luxica Pharma Inc Gujarat 2025-26
Shree Pharma (India) Gujarat 2025-26
Adani Pharmachem Pvt. Ltd. Gujarat 2025-26
Unimark Remedies Ltd. Gujarat 2025-26
Sehat Pharma Pvt. Ltd. Gujarat 2025-26
Sg Healthcare Pvt. Ltd. Gujarat 2025-26
Elikem Pharmaceuticals Pvt. Ltd. Gujarat 2025-26
Techno Drugs And Intermediates Pvt. Ltd. Gujarat 2025-26
Suchem Laboratories Gujarat 2025-26
Krozex Remedies Pvt. Ltd. Gujarat 2025-26
Nebula Healthcare Ltd. Gujarat 2025-26
Divine Life Care Pvt. Ltd. Gujarat 2025-26
Ethicare Pharmaceuticals Pvt. Ltd. Gujarat 2025-26
Vm Chemicals Gujarat 2025-26
Shelat Brothers Gujarat 2025-26
Vadish Pharma Pvt. Ltd. Gujarat 2025-26
Bharat Parenterals Ltd. Gujarat 2025-26
Navin Saxsena Research and Technology Pvt. Ltd. Gujarat 2025-26
Sprout Laboratories Pvt. Ltd. Gujarat 2025-26
Sbf Pharma Pvt. Ltd. Gujarat 2025-26
Carewin Pharmaceuticals Gujarat Pvt. Ltd. Gujarat 2025-26
Lexmark Pharmaceuticals Pvt. Ltd. Gujarat 2025-26
Hbc Healthcare Pvt. Ltd. Gujarat 2025-26
Sruzam Labs Pvt. Ltd. Gujarat 2025-26
Lex-Mark Healthcare LLP Gujarat 2025-26
Indamed Pharmaceuticals Pvt. Ltd. Gujarat 2025-26
Snj Labs Pvt. Ltd. Gujarat 2025-26
Seejar Pharmaceuticals Gujarat 2025-26Shantam Pharmaceuticals Pvt. Ltd. Gujarat 2025-26
Oneiro Lifecare Pvt. Ltd. Gujarat 2025-26
Nira Life Sciences Pvt. Ltd. Gujarat 2025-26
Apex Formulations Pvt. Ltd. Gujarat 2025-26
Dwarkesh Healthcare Gujarat 2025-26
Sunij Pharma Pvt. Ltd. Gujarat 2025-26
Aan Pharma Pvt. Ltd. Gujarat 2025-26
Kekule Life Sciences Ltd. Gujarat 2025-26
Mackur Laboratories Ltd. Gujarat 2025-26
Aurinko Healthcare Pvt. Ltd. Haryana 2025-26
Mitra Industries Pvt. Ltd. Haryana 2025-26
Sia Pharma Pvt. Ltd. Haryana 2025-26
Medox Lifesciences Himachal Pradesh 2025-26
Pushkar Pharma Himachal Pradesh 2025-26
Legency Remedies Pvt. Ltd. Himachal Pradesh 2025-26
Pentachem Pharmaceuticals Himachal Pradesh 2025-26
Sunlife Pharma Services Himachal Pradesh 2025-26
Smayan Healthcare Pvt. Ltd. Himachal Pradesh 2025-26
Soft Touch Pharmaceuticals Pvt. Ltd. Himachal Pradesh 2025-26
Magbro Health Care Pvt. Ltd. Himachal Pradesh 2025-26
Pinnacle Life Science Pvt. Ltd Himachal Pradesh 2025-26
Orison Pharma International Himachal Pradesh 2025-26
Brooks Laboratories Ltd. Himachal Pradesh 2025-26
Aqua Parental Himachal Pradesh 2025-26
Athens Life Sciences Himachal Pradesh 2025-26
Cortex Medical Inc Himachal Pradesh 2025-26
Himsagar Laboratories Ltd. Himachal Pradesh 2025-26
Saar Biotech Pvt. Ltd. Himachal Pradesh 2025-26
Syskem Pharmocrats Himachal Pradesh 2025-26
Mmg Healthcare Himachal Pradesh 2025-26
Verax Lifesciences Pvt. Ltd. Himachal Pradesh 2025-26
Auraya Healthcare Himachal Pradesh 2025-26
Lifecare Neuro Products Ltd Himachal Pradesh 2025-26
Hanuchem Laboratories Unit Three Himachal Pradesh 2025-26
Martin & Brown Bio Sciences Pvt. Ltd. Himachal Pradesh 2025-26
Nitin Lifesciences Ltd Himachal Pradesh 2025-26
Pacific India Himachal Pradesh 2025-26
Vellinton Healthcare Himachal Pradesh 2025-26
Digital Vision Himachal Pradesh 2025-26
Kantil Pharmaceuticals Pvt. Ltd. Himachal Pradesh 2025-26
Ekanthika Pharmaceuticals Himachal Pradesh 2025-26
Ramom Health Care Pvt. Ltd. Himachal Pradesh 2025-26
Ethicare Laboratories Jammu and Kashmir 2025-26
Adeep Life Sciences Pvt. Ltd. Karnataka 2025-26
Vazrachem Specialities Karnataka 2025-26
Natural Capsules Ltd. Karnataka 2025-26
M N Chemicals Ltd. Karnataka 2025-26
Garima Healthcare Pvt. Ltd. Madhya Pradesh 2025-26Riemann Labs Pvt. Ltd. Madhya Pradesh 2025-26
Wilcure Remedies Pvt. Ltd. Madhya Pradesh 2025-26
Cipco Ltd. Madhya Pradesh 2025-26
Arc Pharmaceuticals Madhya Pradesh 2025-26
Sam Kem Madhya Pradesh 2025-26
Oceanic Laboratories Pvt. Ltd. Maharashtra 2025-26
Galentic Pharma India Pvt. Ltd. Maharashtra 2025-26
Red Cross Formulation Maharashtra 2025-26
M J Biopharm Pvt. Ltd. Maharashtra 2025-26
Anant Pharmaceuticals Pvt. Ltd. Maharashtra 2025-26
Arco Life Science (India) Private Ltd Maharashtra 2025-26
Unilab Chemicals And Pharmaceuticals Pvt. Ltd. Maharashtra 2025-26
Zen Chemicals Pvt. Ltd. Maharashtra 2025-26
Orex Pharma Pvt. Ltd. Maharashtra 2025-26
Pell Tech Health Care Pvt. Ltd. Maharashtra 2025-26
U S Pharma (India) Pvt. Ltd. Maharashtra 2025-26
Eisen Pharmaceutical Co Pvt. Ltd. Maharashtra 2025-26
Bakul Aromatics and Chemicals Pvt. Ltd. Maharashtra 2025-26
Sydler Remedies Pvt. Ltd. Maharashtra 2025-26
Stantech Pharmaceuticals Pvt. Ltd. Maharashtra 2025-26
Laxachem Organics Pvt. Ltd. Maharashtra 2025-26
Sanpras Health Care Pvt. Ltd. Maharashtra 2025-26
Flamingo Pharmaceuticals Ltd. Maharashtra 2025-26
Shakti Life Science Pvt. Ltd. Maharashtra 2025-26
Asuwaldi Pharmaceuticals Maharashtra 2025-26
Leben Laboratories Pvt. Ltd. Maharashtra 2025-26
Surajlok Chemicals Pvt. Ltd. Maharashtra 2025-26
Korten Pharmaceuticals Pvt. Ltd. Maharashtra 2025-26
Makjai Laboratories Pvt. Ltd. Maharashtra 2025-26
Hindustan Laboratories Ltd. Maharashtra 2025-26
Nysa Biomed Pvt. Ltd. Maharashtra 2025-26
Gag Pharmaceuticals Punjab 2025-26
Kwality Pharmaceuticals Ltd. Punjab 2025-26
D. D. Pharmaceuticals Pvt. Ltd. Rajasthan 2025-26
D. D. Api Pvt. Ltd. Rajasthan 2025-26
Sundara Raman R Tamil Nadu 2025-26
Life Care Formulations Pvt. Ltd. Tamil Nadu 2025-26
Bafna Pharmaceuticals Ltd. Tamil Nadu 2025-26
Linux Life Sciences Pvt. Ltd. Tamil Nadu 2025-26
Maithri Drugs Pvt. Ltd. Telangana 2025-26
Yeluri Formulations Pvt. Ltd. Telangana 2025-26
Rashmi Pharma Pvt. Ltd. Telangana 2025-26
Kekule Pharma Ltd. Telangana 2025-26
Indo Gulf Pharmaceuticals Uttar Pradesh 2025-26
Psychotropics India Ltd. Uttarakhand 2025-26
Saintlife Pharmaceuticals Ltd. Uttarakhand 2025-26
Sushima Laboratories Uttarakhand 2025-26
Dhruv Bhatia- Supermax Laboratories Uttarakhand 2025-26Sunlife Sciences Uttarakhand 2025-26
Coral Laboratories Ltd. Uttarakhand 2025-26
Suraksha Pharma Pvt. Ltd. Uttarakhand 2025-26
Suncare Formulations Pvt. Ltd. Uttarakhand 2025-26
Synokem Lifesciences Pvt. Ltd. Uttarakhand 2025-26Annexure III
Statement referred to in reply to part (a) of the LOK SABHA UNSTARRED Q. NO.
2252 for answer on 1.8.2025
List of SPVs whose projects have been considered and approved or approved in-
principle under API-CF
(in crore ₹)
Sanctioned
S. Sanctioned Grant
SPV State Project in financial
No. grant released
year
1 Welzo Research and Baddi, Research and 19.53 17.58 2022-23
Development Pvt. Himachal Development and
Ltd. Pradesh Testing Laboratory
2 Jeedimetla Effluent Hyderabad, Common Effluent 20.00 18 2022-23
Treatment Ltd. Telangana Treatment Plant
3 Tindivanam Pharma Villupuram, Common Effluent 15.88 6 2022-23
Park Association Tamil Nadu Treatment Plant
4 Devbhumi Roorkee, Testing Laboratory 20.00 18 2022-23
Pharmaceutical Uttarakhand
Analytical Testing
and Training
Foundation
5 Triupati Research and Tirupati, Common Facility 20.00 5 2023-24
Development Pvt. Andhra Centre for Research
Ltd. Pradesh and Development
and Testing and
Training facility
6 Telangana Hyderabad, Centre of 18.87 4.71 2023-24
Lifesciences Telangana Excellence on
Foundation (earlier Antimicrobial
Hyderabad Resistance
Pharmacity Ltd.)
7 Inducare Pune, Upgradation of 7.18 6.47 2024-25
Pharmaceuticals and Maharashtra Common Testing
Research Foundation Facility Quality
Control Laboratory
8 Himachal Pradesh Baddi, Common Facility 17.87 0 2025-26
Testing Lab Ltd. — Himachal Centre for Research
In-principle approval Pradesh and Skill
Development and
Centre of
Excellence
Total 139.33 75.76
*****